NO20003916L - Benzotiadiazoler og derivater - Google Patents

Benzotiadiazoler og derivater

Info

Publication number: NO20003916L
Authority: NO; Norway
Prior art keywords: benzothiadiazoles; derivatives
Prior art date: 1998-02-03

Application number

NO20003916A

Other languages

English (en)

Other versions

NO20003916D0 (no

NO316913B1 (no

Inventor

Bernhard Peter Neumann

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-03

Filing date

2000-08-02

Publication date

2000-09-28

2000-08-02 Application filed by Novartis Ag filed Critical Novartis Ag

2000-08-02 Publication of NO20003916D0 publication Critical patent/NO20003916D0/no

2000-09-28 Publication of NO20003916L publication Critical patent/NO20003916L/no

2004-06-21 Publication of NO316913B1 publication Critical patent/NO316913B1/no

Links

FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical class C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Addiction (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Virology (AREA)
Gynecology & Obstetrics (AREA)
Tropical Medicine & Parasitology (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Orthopedic Medicine & Surgery (AREA)
Nutrition Science (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)

NO20003916A 1998-02-03 2000-08-02 Benzotiadiazoler og derivater NO316913B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9802251.0A GB9802251D0 (en)	1998-02-03	1998-02-03	Organic compounds
PCT/EP1999/000622 WO1999040089A1 (en)	1998-02-03	1999-02-01	Benzothiadiazoles and derivatives

Publications (3)

Publication Number	Publication Date
NO20003916D0 NO20003916D0 (no)	2000-08-02
NO20003916L true NO20003916L (no)	2000-09-28
NO316913B1 NO316913B1 (no)	2004-06-21

Family

ID=10826354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003916A NO316913B1 (no)	1998-02-03	2000-08-02	Benzotiadiazoler og derivater

Country Status (29)

Country	Link
EP (1)	EP1049694B1 (no)
JP (1)	JP3455180B2 (no)
KR (2)	KR100502880B1 (no)
CN (1)	CN1119346C (no)
AR (1)	AR015222A1 (no)
AT (1)	ATE217622T1 (no)
AU (1)	AU745051B2 (no)
BR (1)	BR9909739A (no)
CA (1)	CA2318977A1 (no)
CO (1)	CO4990932A1 (no)
DE (1)	DE69901483T2 (no)
DK (1)	DK1049694T3 (no)
ES (1)	ES2178451T3 (no)
GB (1)	GB9802251D0 (no)
HU (1)	HUP0100978A3 (no)
ID (1)	ID26156A (no)
IL (1)	IL137332A (no)
MY (1)	MY122453A (no)
NO (1)	NO316913B1 (no)
NZ (1)	NZ505970A (no)
PE (1)	PE20000246A1 (no)
PL (1)	PL194838B1 (no)
PT (1)	PT1049694E (no)
RU (1)	RU2219177C2 (no)
SK (1)	SK283833B6 (no)
TR (1)	TR200002237T2 (no)
TW (1)	TW509689B (no)
WO (1)	WO1999040089A1 (no)
ZA (1)	ZA99800B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL139197A0 (en) *	1999-10-29	2001-11-25	Pfizer Prod Inc	Use of corticotropin releasing factor antagonists and related compositions
PE20030008A1 (es)	2001-06-19	2003-01-22	Bristol Myers Squibb Co	Inhibidores duales de pde 7 y pde 4
GB0302876D0 (en) *	2003-02-07	2003-03-12	Novartis Ag	Organic compounds
PL2368554T3 (pl)	2003-04-08	2015-05-29	Progenics Pharm Inc	Preparaty farmaceutyczne zawierające metylonaltrekson
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
GB0525068D0 (en)	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
US10166271B2 (en)	2006-06-21	2019-01-01	The Regents Of The University Of California	Methods for promoting hair growth
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
JP5469593B2 (ja)	2007-03-29	2014-04-16	ワイス・エルエルシー	末梢性オピオイド受容体アンタゴニストおよびその使用
WO2008121348A2 (en)	2007-03-29	2008-10-09	Progenics Pharmaceuticals, Inc.	Peripheral opioid receptor antagonists and uses thereof
MX2009010550A (es)	2007-03-29	2009-12-14	Progenics Pharm Inc	Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
AU2008349873B2 (en)	2008-02-06	2014-02-13	Progenics Pharmaceuticals, Inc.	Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
CN102762572A (zh)	2010-02-01	2012-10-31	诺瓦提斯公司	作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es)	2010-02-01	2012-03-07	Novartis Ag	Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en)	2010-02-02	2014-10-15	Novartis AG	Cyclohexyl amide derivatives as crf receptor antagonists
UY34094A (es)	2011-05-27	2013-01-03	Novartis Ag	Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
WO2013164790A1 (en)	2012-05-03	2013-11-07	Novartis Ag	L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists
EP3510029B1 (en) *	2016-09-07	2025-11-05	The Regents of The University of California	Allosteric corticotropin-releasing factor receptor 1 (crfr1) antagonists that decrease p-tau and improve cognition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2499991A1 (fr) *	1981-02-19	1982-08-20	Sandoz Sa	Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
TW241263B (no) *	1991-08-22	1995-02-21	Hoechst Roussel Pharma
KR0163624B1 (ko) *	1992-04-28	1998-12-01	오노다 마사요시	신규의 치환된 3급 아미노 화합물 또는 이의 염
GB9323290D0 (en) *	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives

1998
- 1998-02-03 GB GBGB9802251.0A patent/GB9802251D0/en not_active Ceased
1999
- 1999-01-27 CO CO99004377A patent/CO4990932A1/es unknown
- 1999-01-29 MY MYPI99000329A patent/MY122453A/en unknown
- 1999-02-01 CN CN99802662A patent/CN1119346C/zh not_active Expired - Fee Related
- 1999-02-01 JP JP2000530518A patent/JP3455180B2/ja not_active Expired - Fee Related
- 1999-02-01 PE PE1999000070A patent/PE20000246A1/es not_active Application Discontinuation
- 1999-02-01 TR TR2000/02237T patent/TR200002237T2/xx unknown
- 1999-02-01 RU RU2000123169/04A patent/RU2219177C2/ru not_active IP Right Cessation
- 1999-02-01 AT AT99934200T patent/ATE217622T1/de not_active IP Right Cessation
- 1999-02-01 AU AU32521/99A patent/AU745051B2/en not_active Ceased
- 1999-02-01 HU HU0100978A patent/HUP0100978A3/hu unknown
- 1999-02-01 CA CA002318977A patent/CA2318977A1/en not_active Abandoned
- 1999-02-01 SK SK1157-2000A patent/SK283833B6/sk unknown
- 1999-02-01 IL IL13733299A patent/IL137332A/xx active IP Right Grant
- 1999-02-01 AR ARP990100410A patent/AR015222A1/es not_active Application Discontinuation
- 1999-02-01 PT PT99934200T patent/PT1049694E/pt unknown
- 1999-02-01 ES ES99934200T patent/ES2178451T3/es not_active Expired - Lifetime
- 1999-02-01 DE DE69901483T patent/DE69901483T2/de not_active Expired - Lifetime
- 1999-02-01 NZ NZ505970A patent/NZ505970A/xx unknown
- 1999-02-01 PL PL342008A patent/PL194838B1/pl not_active IP Right Cessation
- 1999-02-01 DK DK99934200T patent/DK1049694T3/da active
- 1999-02-01 EP EP99934200A patent/EP1049694B1/en not_active Expired - Lifetime
- 1999-02-01 ID IDW20001473A patent/ID26156A/id unknown
- 1999-02-01 BR BR9909739-7A patent/BR9909739A/pt not_active Application Discontinuation
- 1999-02-01 KR KR10-2004-7015274A patent/KR100502880B1/ko not_active Expired - Fee Related
- 1999-02-01 KR KR10-2000-7008418A patent/KR100507250B1/ko not_active Expired - Fee Related
- 1999-02-01 WO PCT/EP1999/000622 patent/WO1999040089A1/en not_active Ceased
- 1999-02-02 ZA ZA9900800A patent/ZA99800B/xx unknown
- 1999-02-24 TW TW088102726A patent/TW509689B/zh not_active IP Right Cessation
2000
- 2000-08-02 NO NO20003916A patent/NO316913B1/no unknown

Also Published As

Publication number	Publication date
AR015222A1 (es)	2001-04-18
DK1049694T3 (da)	2002-09-09
AU3252199A (en)	1999-08-23
NO20003916D0 (no)	2000-08-02
ZA99800B (en)	1999-08-03
BR9909739A (pt)	2001-03-20
CO4990932A1 (es)	2000-12-26
RU2219177C2 (ru)	2003-12-20
JP2002502853A (ja)	2002-01-29
ES2178451T3 (es)	2002-12-16
KR100507250B1 (ko)	2005-08-10
KR20040097226A (ko)	2004-11-17
EP1049694A1 (en)	2000-11-08
PL194838B1 (pl)	2007-07-31
IL137332A (en)	2005-11-20
PE20000246A1 (es)	2000-05-15
ATE217622T1 (de)	2002-06-15
CN1119346C (zh)	2003-08-27
JP3455180B2 (ja)	2003-10-14
NO316913B1 (no)	2004-06-21
PT1049694E (pt)	2002-09-30
GB9802251D0 (en)	1998-04-01
HUP0100978A2 (hu)	2002-05-29
KR20010040550A (ko)	2001-05-15
SK11572000A3 (sk)	2001-02-12
CN1289334A (zh)	2001-03-28
KR100502880B1 (ko)	2005-07-21
WO1999040089A1 (en)	1999-08-12
HK1033578A1 (en)	2001-09-07
CA2318977A1 (en)	1999-08-12
NZ505970A (en)	2003-03-28
HUP0100978A3 (en)	2003-08-28
SK283833B6 (sk)	2004-03-02
MY122453A (en)	2006-04-29
PL342008A1 (en)	2001-05-07
TR200002237T2 (tr)	2000-12-21
ID26156A (id)	2000-11-30
AU745051B2 (en)	2002-03-07
EP1049694B1 (en)	2002-05-15
DE69901483T2 (de)	2002-10-31
IL137332A0 (en)	2001-07-24
TW509689B (en)	2002-11-11
DE69901483D1 (de)	2002-06-20

Publication	Publication Date	Title
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
IS6385A (is)	2002-05-15	Ný notkun og nýjar N-asabísýkló-amíð afleiður
NO20032753D0 (no)	2003-06-17	Forbindelse og anvendelse derav
NO20010193L (no)	2001-01-12	Tiobenzimidazol-derivater
NO20003916D0 (no)	2000-08-02	Benzotiadiazoler og derivater
DK0930302T3 (da)	2003-07-21	Benzosulfonderivater
NO20010514D0 (no)	2001-01-30	Aminometylkarboksylsyre-derivater
NO995784D0 (no)	1999-11-25	Fytosterol og/eller fytosterolderivater
ATE259810T1 (de)	2004-03-15	Phenyl-xanthinderivate
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
NO20013237D0 (no)	2001-06-28	3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO986174D0 (no)	1998-12-29	Triazinderivater og anvendelse derav
DK1115716T3 (da)	2003-02-24	2-phenylpyran-4-on-derivater
ATE229503T1 (de)	2002-12-15	Cyclohexandiol-derivate
DK1134219T3 (da)	2005-10-17	Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de)	2003-03-15	Chromanderivate
DK1140952T3 (da)	2004-01-12	Phosphororganiske forbindelser og anvendelse heraf
DK1060183T3 (da)	2003-08-11	5-deoxycytidinderivater
ATE217621T1 (de)	2002-06-15	Thiazol-derivate
DE59907635D1 (de)	2003-12-11	Pyrazolyldioxothiochromanoyl-derivate
ID26654A (id)	2001-01-25	Paroksetin askorbat
ATE250025T1 (de)	2003-10-15	Hydrazin-derivate
NO993112A (no)	2000-02-14	Katamaran og trimaranski
FI980691A0 (fi)	1998-03-26	Xylitoltillsats i roektobak
UA2172S (uk)	1998-08-31	Календар-довідник перекидний